| 國立成功大學 |
2022 |
Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts
|
Tsai, Y.-T.;Li, C.-Y.;Huang, Y.-H.;Chang, T.-S.;Lin, C.-Y.;Chuang, Chuang C.-H.;Wang, C.-Y.;Anuraga, G.;Chang, T.-H.;Shih, T.-C.;Lin, Z.-Y.;Chen, Y.-L.;Chung, I.;Lee, K.-H.;Chang, Chang C.-C.;Sung, Sung S.-Y.;Yang, K.-H.;Tsui, W.-L.;Yap, C.-V.;Wu, M.-H. |
| 國立成功大學 |
2022 |
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors
|
Chan, S.L.;Schuler, M.;Kang, Y.-K.;Yen, C.-J.;Edeline, J.;Choo, S.P.;Lin, C.-C.;Okusaka, T.;Weiss, K.-H.;Macarulla, T.;Cattan, S.;Blanc, J.-F.;Lee, K.-H.;Maur, Maur M.;Pant, S.;Kudo, M.;Assenat, E.;Zhu, A.X.;Yau, T.;Lim, H.Y.;Bruix, J.;Geier, A.;Guill�n-Ponce, C.;Fasolo, A.;Finn, R.S.;Fan, J.;Vogel, A.;Qin, S.;Riester, M.;Katsanou, V.;Chaudhari, M.;Kakizume, T.;Gu, Y.;Porta, D.G.;Myers, A.;Delord, J.-P. |
| 國立成功大學 |
2022 |
Rasch Modeling and Multilevel Confirmatory Factor Analysis for the Usability of the Impact of Event Scale-Revised (IES-R) during the COVID-19 Pandemic
|
Aljaberi, M.A.;Lee, K.-H.;Alareqe, N.A.;Qasem, M.A.;Alsalahi, Alsalahi A.;Abdallah, Abdallah A.M.;Noman, S.;Al-Tammemi, Al-Tammemi A.B.;Mohamed, Ibrahim M.I.;Lin, C.-Y. |
| 國立成功大學 |
2022 |
Nephrotoxins and acute kidney injury – The consensus of the Taiwan acute kidney injury Task Force
|
Huang, W.-C.;Wang, M.-T.;Lai, T.-S.;Lee, K.-H.;Shao, Shao S.-C.;Chen, Chen C.-H.;Su, C.-H.;Chen, Y.-T.;Sung, J.-M.;Chen, Y.-C. |
| 臺大學術典藏 |
2021-11-30T04:53:53Z |
Nationwide epidemiology and prognosis of dialysis-requiring acute kidney injury (NEP-AKI-D) study: Design and methods
|
Shiao C.-C.; Wu P.-C.; VIN-CENT WU; Lin J.-H.; Pan H.-C.; Yang Y.-F.; Lai T.-S.; Huang T.-M.; Wu C.-H.; Yang W.-S.; Wu C.-J.; Kao C.-C.; Sun C.-Y.; Huang C.-T.; Lee K.-H.; Lin C.-Y.; Chen T.-C.; Hu F.-C.; Liou H.-H.; Lu K.-C.; Chien K.-L.; Wang J.-J.; Kan W.-C.; Kuo F.-C.; Lin H.Y.-H.; Chen C.-M.; You Z.-H.; Tsai J.-P.; Weng C.-J.; Chen H.-Y.; Chang C.-F.; Hsu W.-D.; Wu M.-S.; Huang C.-C.; Wu K.-D.; on behalf of the Taiwan Consortium for Acute Kidney Injury Renal Diseases (CAKs) |
| 臺大學術典藏 |
2021-11-30T04:53:40Z |
Norepinephrine administration is associated with higher mortality in dialysis requiring acute kidney injury patients with septic shock
|
Chen Y.-Y.; VIN-CENT WU; Huang W.-C.; Yeh Y.-C.; Wu M.-S.; Huang C.-C.; Wu K.-D.; Fang J.-T.; Wu C.-J.; VIN-CENT WU; Lai T.-S.; Lin Y.-F.; Tsai I.-J.; Lai C.-F.; Huang T.-M.; Chu T.-S.; Chen Y.-M.; Chang Y.-H.; Yeh Y.-C.; Lai C.-H.; Tseng L.-J.; Wu K.-D.; Wang J.-J.; Chen C.-Y.; Shiao C.-C.; Wang W.-J.; Lin J.-H.; Wu C.-H.; Wu C.-J.; Lu K.-C.; Kan W.-C.; Huang C.-C.; Chou C.-Y.; Yang Y.-F.; Tsai J.-P.; Hu F.-C.; Lee C.-T.; Chen J.-B.; Lee C.-H.; Lee W.-C.; Li L.-C.; Chen T.-C.; Lin H.Y.-H.; Chen Y.-C.; Lee C.-C.; Sun C.-Y.; Pan H.-C.; Chang M.-Y.; Jenq C.-C.; Lin C.-Y.; Chang C.-H.; Tsai T.-Y.; Chen C.-M.; Lin E.-T.; Wu C.-J.; Lin C.-J.; Wu P.-C.; Kuo F.-C.; Weng C.-J.; Chen L.-K.; Lin S.-L.; Yang W.-S.; Hsu W.-D.; Leu J.-G.; Chang J.-T.; Liou H.-H.; Hsu K.-H.; Wu M.-J.; Huang C.-T.; You Z.-H.; Chang C.-F.; Chen T.-W.; Chen H.-H.; Chang F.-C.; Lin Y.-C.; Wu M.-S.; Kao C.-C.; Hung S.-C.; Kuo K.-L.; Wu C.-H.; Tarng D.-C.; Chen J.-Y.; Yang C.-Y.; Lee K.-H.; Ko S.-W.; The NSARF, CAKS Group |
| 臺大學術典藏 |
2021-10-06T08:04:50Z |
Norepinephrine administration is associated with higher mortality in dialysis requiring acute kidney injury patients with septic shock
|
Chen Y.-Y.; Wu V.-C.; Huang W.-C.; Yeh Y.-C.; Wu M.-S.; Huang C.-C.; Wu K.-D.; Fang J.-T.; Wu C.-J.; Wu V.-C.; Lai T.-S.; Lin Y.-F.; I-JUNG TSAI; Lai C.-F.; Huang T.-M.; Chu T.-S.; Chen Y.-M.; Chang Y.-H.; Yeh Y.-C.; Lai C.-H.; Tseng L.-J.; Wu K.-D.; Wang J.-J.; Chen C.-Y.; Shiao C.-C.; Wang W.-J.; Lin J.-H.; Wu C.-H.; Wu C.-J.; Lu K.-C.; Kan W.-C.; Huang C.-C.; Chou C.-Y.; Yang Y.-F.; Tsai J.-P.; Hu F.-C.; Lee C.-T.; Chen J.-B.; Lee C.-H.; Lee W.-C.; Li L.-C.; Chen T.-C.; Lin H.Y.-H.; Chen Y.-C.; Lee C.-C.; Sun C.-Y.; Pan H.-C.; Chang M.-Y.; Jenq C.-C.; Lin C.-Y.; Chang C.-H.; Tsai T.-Y.; Chen C.-M.; Lin E.-T.; Wu C.-J.; Lin C.-J.; Wu P.-C.; Kuo F.-C.; Weng C.-J.; Chen L.-K.; Lin S.-L.; Yang W.-S.; Hsu W.-D.; Leu J.-G.; Chang J.-T.; Liou H.-H.; Hsu K.-H.; Wu M.-J.; Huang C.-T.; You Z.-H.; Chang C.-F.; Chen T.-W.; Chen H.-H.; Chang F.-C.; Lin Y.-C.; Wu M.-S.; Kao C.-C.; Hung S.-C.; Kuo K.-L.; Wu C.-H.; Tarng D.-C.; Chen J.-Y.; Yang C.-Y.; Lee K.-H.; Ko S.-W.; The NSARF, CAKS Group |
| 臺大學術典藏 |
2021-09-04T06:11:33Z |
Reimbursement policies in the Asia-Pacific for chronic hepatitis B
|
Lim S.G.; Amarapurkar D.N.; Chan H.L.-Y.; Crawford D.H.; Gane E.J.; Han K.-H.; Ahn S.H.; Jafri W.; Jia J.; JIA-HORNG KAO; Lesmana L.A.; Lesmana C.R.A.; Mohamed R.; Phiet P.H.; Piratvisuth T.; Sarin S.K.; Sollarno J.D.; Eguchi Y.; Mahtab M.-A.; Lee K.H. |
| 臺大學術典藏 |
2021-08-31T06:29:21Z |
Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population
|
Lin C.-H.; Yap Y.S.; Lee K.-H.; Im S.-A.; Naito Y.; Yeo W.; Ueno T.; Kwong A.; Li H.; Huang S.-M.; Leung R.; Han W.; Tan B.; Hu F.-C.; Huang C.-S.; ANN-LII CHENG; Lu Y.-S.; Asian Breast Cancer Cooperative Group |
| 臺大學術典藏 |
2021-08-24T02:10:13Z |
Nationwide epidemiology and prognosis of dialysis-requiring acute kidney injury (NEP-AKI-D) study: Design and methods
|
Shiao C.-C.; Wu P.-C.; Wu V.-C.; Lin J.-H.; Pan H.-C.; Yang Y.-F.; Lai T.-S.; TAO-MIN HUANG; Wu C.-H.; Yang W.-S.; Wu C.-J.; Kao C.-C.; Sun C.-Y.; Huang C.-T.; Lee K.-H.; Lin C.-Y.; Chen T.-C.; Hu F.-C.; Liou H.-H.; Lu K.-C.; Chien K.-L.; Wang J.-J.; Kan W.-C.; Kuo F.-C.; Lin H.Y.-H.; Chen C.-M.; You Z.-H.; Tsai J.-P.; Weng C.-J.; Chen H.-Y.; Chang C.-F.; Hsu W.-D.; Wu M.-S.; Huang C.-C.; Wu K.-D.; on behalf of the Taiwan Consortium for Acute Kidney Injury Renal Diseases (CAKs) |
| 臺大學術典藏 |
2021-07-28T06:46:37Z |
Treating HR+/HER2? breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression
|
Yeo W.; Ueno T.; CHING-HUNG LIN; Liu Q.; Lee K.-H.; Leung R.; Naito Y.; Park Y.H.; Im S.-A.; Li H.; Yap Y.S.; Lu Y.-S.; The Asian Breast Cancer Cooperative Group |
| 臺大學術典藏 |
2021-07-26T10:01:31Z |
DockCoV2: A drug database against SARS-CoV-2
|
Chen T.-F;Chang Y.-C;Hsiao Y;Lee K.-H;Hsiao Y.-C;Lin Y.-H;Tu Y.-C.E;Huang H.-C;Chen C.-Y;Juan H.-F.; Chen T.-F; Chang Y.-C; Hsiao Y; Lee K.-H; Hsiao Y.-C; Lin Y.-H; Tu Y.-C.E; Huang H.-C; Chen C.-Y; Juan H.-F.; CHIEN-YU CHEN |
| 臺大學術典藏 |
2021-07-02T03:42:43Z |
Reduction of human-to-pig cellular response by alteration of porcine MHC with human HLA DPW0401 exogenes
|
Lee J.-M.; Tu C.-F.; Yang P.-W.; Lee K.-H.; Tsuji K.; Tsai M.-K.; Chen R.J.; Hu C.-Y.; Hsieh R.-P.; Tai H.-C.; BOR-LUEN CHIANG; Weng C.-N.; Lee Y.-C.; Lee C.-J. |
| 臺大學術典藏 |
2021-06-04T03:32:10Z |
Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation
|
Chiang W.-F.; Cheng T.-M.; Chang C.-C.; SZU-HUA PAN; Changou C.A.; Chang T.-H.; Lee K.-H.; Wu S.-Y.; Chen Y.-F.; Chuang K.-H.; Shieh D.-B.; Chen Y.-L.; Tu C.-C.; Tsui W.-L.; Wu M.-H. |
| 臺大學術典藏 |
2021-06-02T05:43:58Z |
CHM-1 inhibits hepatocyte growth factor-induced invasion of SK-Hep-1 human hepatocellular carcinoma cells by suppressing matrix metalloproteinase-9 expression
|
Wang S.-W.; Pan S.-L.; Peng C.-Y.; Huang D.-Y.; Tsai A.-C.; Chang Y.-L.; JIH-HWA GUH; Kuo S.-C.; Lee K.-H.; Teng C.-M. |
| 臺大學術典藏 |
2021-06-02T05:43:57Z |
CHM-1, a novel synthetic quinolone with potent and selective antimitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivo
|
Wang S.-W.; Pan S.-L.; Huang Y.-C.; JIH-HWA GUH; Chiang P.-C.; Huang D.-Y.; Kuo S.-C.; Lee K.-H.; Teng C.-M. |
| 臺大學術典藏 |
2021-06-02T05:43:49Z |
A unique P-glycoprotein interacting agent displays anticancer activity against hepatocellular carcinoma through inhibition of GRP78 and mTOR pathways
|
Kuo T.-C.; Chiang P.-C.; Yu C.-C.; Nakagawa-Goto K.; Bastow K.F.; Lee K.-H.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-06-02T05:43:48Z |
Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activator
|
Lee K.-H.; Hsu E.-C.; JIH-HWA GUH; Yang H.-C.; Wang D.; Kulp S.K.; Shapiro C.L.; Chen C.-S. |
| 臺大學術典藏 |
2021-05-31T06:18:04Z |
Cardiac glycosides from antiaris toxicaria with potent cardiotonic activity
|
Shi L.-S.; Liao Y.-R.; MING-JAI SU; Lee A.-S.; Kuo P.-C.; Damu A.G.; Kuo S.-C.; Sun H.-D.; Lee K.-H.; Wu T.-S. |
| 臺大學術典藏 |
2021-05-28T02:07:26Z |
DockCoV2: a drug database against SARS-CoV-2
|
Chen, T.-F., Chang, Y.-C., Hsiao, Y., Lee, K.-H., Hsiao, Y.-C., Lin, Y.-H., Tu, Y.-C. E., Huang, H.-C., Chen, C.-Y., Juan, H.-F.; Chen, T.-F.; Chang, Y.-C.; Hsiao, Y.; Lee, K.-H.; Hsiao, Y.-C.; Lin, Y.-H.; Tu, Y.-C. E.; Huang, H.-C.; Chen, C.-Y.; Juan, H.-F. |
| 臺大學術典藏 |
2021-04-23T05:56:32Z |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
|
Park K.;Vansteenkiste J.;Lee K.H.;Pentheroudakis G.;Zhou C.;Prabhash K.;Seto T.;Voon P.J.;Tan D.S.W.;Chih-Hsin Yang;Wang J.;Babu K.G.;Nakayama Y.;Alip A.;Chua K.L.M.;Cheng J.C.-H.;Senan S.;Ahn Y.C.;Kim T.-Y.;Ahn H.K.;Peters S.;Yoshino T.;Douillard J.-Y.; Park K.; Vansteenkiste J.; Lee K.H.; Pentheroudakis G.; Zhou C.; Prabhash K.; Seto T.; Voon P.J.; Tan D.S.W.; CHIH-HSIN YANG; Wang J.; Babu K.G.; Nakayama Y.; Alip A.; Chua K.L.M.; Cheng J.C.-H.; Senan S.; Ahn Y.C.; Kim T.-Y.; Ahn H.K.; Peters S.; Yoshino T.; Douillard J.-Y. |
| 臺大學術典藏 |
2021-04-23T05:56:27Z |
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor�VNaive ALK-Positive Non�VSmall Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial
|
Camidge D.R.;Kim H.R.;Ahn M.-J.;Chih-Hsin Yang;Han J.-Y.;Hochmair M.J.;Lee K.H.;Delmonte A.;Garc?A Campelo M.R.;Kim D.-W.;Griesinger F.;Felip E.;Califano R.;Spira A.;Gettinger S.N.;Tiseo M.;Lin H.M.;Gupta N.;Hanley M.J.;Ni Q.;Zhang P.;Popat S.; Camidge D.R.; Kim H.R.; Ahn M.-J.; CHIH-HSIN YANG; Han J.-Y.; Hochmair M.J.; Lee K.H.; Delmonte A.; Garc?a Campelo M.R.; Kim D.-W.; Griesinger F.; Felip E.; Califano R.; Spira A.; Gettinger S.N.; Tiseo M.; Lin H.M.; Gupta N.; Hanley M.J.; Ni Q.; Zhang P.; Popat S. |
| 臺大學術典藏 |
2021-04-23T05:56:27Z |
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial
|
Wu Y.-L.;Cheng Y.;Zhou J.;Lu S.;Zhang Y.;Zhao J.;Kim D.-W.;Soo R.A.;Kim S.-W.;Pan H.;Chen Y.-M.;Chian C.-F.;Liu X.;Tan D.S.W.;Bruns R.;Straub J.;Johne A.;Scheele J.;Park K.;Chih-Hsin Yang;Liu Z.;Chen X.;Wang M.;Yu S.;Zhang H.;Fang J.;Li W.;Yang C.-H.;Chang G.-C.;Hsia T.-C.;Yang C.-T.;Wang C.-C.;Cho B.C.;Lee K.H.;Kim Y.-C.;An H.J.;Woo I.S.;Cho J.Y.;Shin S.W.;Lee J.-S.;Kim J.-H.;Yoo S.S.;Kato T.;Shinagawa N.;Tan S.W.D.;Ngo L.S.-M.;Ratnavelu K.;Ahmad A.R.;Liam C.K.;De Marinis F.;Tassone P.;Molla A.I.;Calles Blanco A.;Lazaro Quintela M.E.;Felip Font E.;Dingemans A.-M.;Bui L.; Wu Y.-L.; Cheng Y.; Zhou J.; Lu S.; Zhang Y.; Zhao J.; Kim D.-W.; Soo R.A.; Kim S.-W.; Pan H.; Chen Y.-M.; Chian C.-F.; Liu X.; Tan D.S.W.; Bruns R.; Straub J.; Johne A.; Scheele J.; Park K.; CHIH-HSIN YANG; Liu Z.; Chen X.; Wang M.; Yu S.; Zhang H.; Fang J.; Li W.; Yang C.-H.; Chang G.-C.; Hsia T.-C.; Yang C.-T.; Wang C.-C.; Cho B.C.; Lee K.H.; Kim Y.-C.; An H.J.; Woo I.S.; Cho J.Y.; Shin S.W.; Lee J.-S.; Kim J.-H.; Yoo S.S.; Kato T.; Shinagawa N.; Tan S.W.D.; Ngo L.S.-M.; Ratnavelu K.; Ahmad A.R.; Liam C.K.; de Marinis F.; Tassone P.; Molla A.I.; Calles Blanco A.; Lazaro Quintela M.E.; Felip Font E.; Dingemans A.-M.; Bui L. |
| 臺大學術典藏 |
2021-04-23T05:56:25Z |
Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non�Vsmall Cell Lung Cancer
|
Yu H.A.;Paz-Ares L.G.;Chih-Hsin Yang;Lee K.H.;Garrido P.;Park K.;Kim J.-H.;Lee D.H.;Mao H.;Wijayawardana S.R.;Gao L.;Hozak R.R.;Chao B.H.;Planchard D.; Yu H.A.; Paz-Ares L.G.; CHIH-HSIN YANG; Lee K.H.; Garrido P.; Park K.; Kim J.-H.; Lee D.H.; Mao H.; Wijayawardana S.R.; Gao L.; Hozak R.R.; Chao B.H.; Planchard D. |
| 臺大學術典藏 |
2021-03-15T07:59:48Z |
Reduction of human-to-pig cellular response by alteration of porcine MHC with human HLA DPW0401 exogenes
|
Lee J.-M.; Tu C.-F.; Yang P.-W.; Lee K.-H.; Tsuji K.; Tsai M.-K.; Chen R.J.; CHUNG-YI HU; Hsieh R.-P.; Tai H.-C.; Chiang B.-L.; Weng C.-N.; Lee Y.-C.; Lee C.-J. |
